山東誠匯醫(yī)藥集團有限公司成立于2002年6月,注冊資本1.3億元,總部位于四面荷花三面柳,一城山色半城湖的歷史文化名城-山東濟南。是一家專注于醫(yī)藥原料藥、中間體、精細化工產(chǎn)品研發(fā)、生產(chǎn)、銷售及服務(wù)一體的高新技術(shù)企業(yè),并致力于MAH、CDMO、獸藥、農(nóng)化等領(lǐng)域的新技術(shù)研發(fā)及應(yīng)用。集團現(xiàn)擁有1個研發(fā)中心-山東誠創(chuàng)藍海醫(yī)藥科技有限公司,1個原料藥廠-山東誠匯雙達藥業(yè)有限公司及兩個醫(yī)藥中間體生產(chǎn)基地,現(xiàn)有職工1000余人,研發(fā)團隊300余人。
產(chǎn)品概況
GMP
鹽酸利多卡因、利多卡因、鹽酸丁卡因、丙胺卡因、塞來昔布、舒更葡糖鈉、奧扎格雷鈉、拉西地平、鹽酸烏拉地爾
I狀態(tài)富馬酸伏諾拉生、克立硼羅 、鹽酸羅哌卡因、丁卡因、鹽酸布比卡因、鹽酸阿替卡因
上報CEP米屈肼(已獲批)、鹽酸羅哌卡因(在審評)、鹽酸阿替卡因(在審評)
US-DMF鹽酸丙胺卡因、丁卡因、鹽酸普莫卡因、富馬酸伏諾拉生
在研來特莫韋、蘆可替尼、非奈利酮、瑪巴洛沙韋、阿帕他胺、他達拉非、氟雷拉納、阿福拉納、沙羅拉納等
*All our products are not offered in countries where valid patents exist. All responsibility with repect to third parties patent rights in specific countries lies exclusively with the buyers.
產(chǎn)品明細
Product Name | 產(chǎn)品名稱 | CAS |
*Vonoprazan Fumarate | 富馬酸伏諾拉生 |
1260141-27-2
881681-01-2
|
*Letermovir | 來特莫韋 | 917389-32-3 |
*Dapagliflozin propanediol monohydrate | 達格列凈一水丙二醇 | 960404-48-2 |
*Crisaborole | 克立硼羅 | 906673-24-3 |
Prilocaine | 丙胺卡因 | 721-50-6 |
Lidocaine hydrochloride | 鹽酸利多卡因 | 6108-05-0 |
Lidocaine | 利多卡因 | 137-58-6 |
Ozagrel sodium | 奧扎格雷鈉 | 189224-26-8 |
Celecoxib | 塞來昔布 | 169590-42-5 |
Ropivacaine hydrochloride | 鹽酸羅哌卡因 | 132112-35-7 |
Sugammadex sodium | 舒更葡糖鈉 | 343306-79-6 |
Tetracaine hydrochloride | 鹽酸丁卡因 | 136-47-0 |
Tetracaine | 丁卡因 | 94-24-6 |
Prilocaine hydrochloride | 鹽酸丙胺卡因 | 1786-81-8 |
Pramoxine hydrochloride | 鹽酸普莫卡因 | 637-58-1 |
Meldonium | 米屈肼 | 86426-17-7 |
Bupivacaine hydrochloride | 鹽酸布比卡因 | 73360-54-0 |
Bupivacaine | 布比卡因 | 2180-92-9 |
Articaine hydrochloride | 鹽酸阿替卡因 | 23964-57-0 |
Tadalafil | 他達那非 | 171596-29-5 |
*Apalutamide | 阿帕他胺 | 956104-40-8 |
*Baloxavir Marboxil | 瑪巴洛沙韋 | 1985606-14-1 |
*Fluralaner | 氟雷拉納 | 864731-61-3 |
*Afoxolaner | 阿福拉納 | 1093861-60-9 |
*Sarolaner | 沙羅拉納 | 1398609-39-6 |
*Ruxolitinib | 蘆可替尼 | 941678-49-5 |
*Finerenone | 非奈利酮 | 1050477-31-0 |
*Upadacitinib | 烏帕替尼 | 1310726-60-3 |
Ozenoxacin | 奧澤沙星 | 245765-41-7 |
Donepezil hydrochloride | 鹽酸多奈哌齊 | 120011-70-3 |
Levobupivacaine hydrochloride | 鹽酸左布比卡因 | 27262-48-2 |
Dibucaine hydrochloride | 鹽酸地布卡因 | CAS:61-12-1 |
Mepivacaine hydrochloride | 鹽酸甲哌卡因 | 1722-62-9 |
Medetomidine hydrochloride | 鹽酸美托咪啶 | 86347-15-1 |
Dyclonine hydrochloride | 鹽酸達克羅寧 | 536-43-6 |
Dienogest | 地諾孕素 | 65928-58-7 |
Altrenogest | 烯丙孕素/四烯雌酮 | 850-52-2 |
Brexanolone | 5alpha-孕甾-3alpha-醇-20-酮 | 516-54-1 |
Metoclopramide | 甲氧氯普胺(胃復(fù)安) | 364-62-5 |
Brinzolamide | 布林佐胺 | 138890-62-7 |
Terbinafine hydrochloride | 鹽酸特比萘芬 | 78628-80-5 |
Mexidole | 美昔得樂 | 127464-43-1 |
Dexmedetomidine hydrochloride | 鹽酸右美托咪定 | 145108-58-3 |
Nadifloxacin | 那氟沙星 | 124858-35-1 |
富馬酸伏諾拉生中間體 Vonoprazan Fumarate Intermediates |
||
5-(2-fluorophenyl)-1H-Pyrrole-3-carboxaldehyde | 5-(2-氟苯基)-1H-吡咯-3-甲醛 | 881674-56-2 |
Pyridine-3-sulfonyl chloride hydrochloride | 吡啶-3-磺酰氯 | 16133-25-8 |
達格列凈中間體 Dapagliflozin Intermediates |
||
5-bromo-2-chloro-4’-ethoxydiphenylmethane | 5-溴-2-氯-4’-乙氧基二苯甲烷 | 461432-23-5 |
[(2R,3R,4R,5S,6S)-3,4,5-triacetyloxy-6-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]oxan-2-yl]methyl acetate | (2R,3R,4R,5S,6S)-2-(乙酰氧基甲基)-6-(4-氯-3-(4-乙氧基芐基)苯基)四氫-2H-吡喃-3,4,5-三yl 三乙酸酯 | 461432-25-7 |
來特莫韋中間體
Letemovir Intermediates
|
||
2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)
-2-oxo-1,2,3,4-tetrahydroquinazolin-4-yl) acetic acid methyl ester
|
2-(8-氟-3-(2-甲氧基-5-(三氟甲基)苯基)-2-氧代-1,2,3,4-四氫喹唑啉-4-基)乙酸甲酯 | 917389-21-0 |
1-(3-Methoxyphenyl)Piperazine Hydrochloride | 1-(3-甲氧基苯基)哌嗪鹽酸鹽 | 16015-70-6 |
克立硼羅中間體
Crisaborole Intermediates
|
||
2-bromo-5-hydroxybenzaldehyde | 2-溴-5-羥基苯甲醛 | 2973-80-0 |
4-[4-bromo-3-(hydroxymethyl)phenoxy]benzonitrile | 4-[4-溴-3-(羥基甲基)苯氧基]苯甲腈 | 906673-45-8 |
[2-bromo-5-(4-cyanophenoxy)phenyl]methyl acetate | 2-溴-5-(4-氰基苯氧基)乙酸芐酯 | 2227126-09-0 |
瑪巴洛沙韋中間體
Baloxavir Marboxil Intermediates
|
||
(R)-7-(benzyloxy)- 3,4,12,12a-tetrahydro- 1H-[1,4]oxazino[3,4- c]pyrido[2,1-f][1,2,4]- triazine-6,8-dione | (R)-7-(芐氧基)-3,4,12,12A-四氫-1H-[1,4]噁嗪[3,4-C]吡啶并[2,1-F] [1,2,4]三嗪-6,8二酮(巴沙洛韋母核) | 1985607-70-2 |
3-(Benzyloxy)-4-oxo-4h-pyran-2-carboxylic acid | 3-(芐氧基)-4-氧代-4H-吡喃-2-羧酸 | 119736-16-2 |
7,8-difluoro-6,11-dihydro-Dibenzo[b,e]thiepin-11-ol | 7,8 -二氟- 6,11 -二氫-二苯并[ B,E ]噻吩并- 11 -醇 | 1985607-83-7 |
非奈利酮中間體 Finerenone Intermediates |
||
4-formyl-3-methoxybenzonitrile | 4-氰基-2-甲氧基苯甲醛 | 21962-45-8 |
4-amino-5-methylpyridone | 4-氨基-5-甲基-2-羥基吡啶 | 95306-64-2 |
2-cyanoethylacetoacetate | 2-氰基乙酰乙酸乙酯 | 65193-87-5 |
2-chloro-5-methylpyridin-4-amine | 2-氯-4-氨基-5-甲基吡啶 | 79055-62-2 |
阿帕他胺中間體 Apalutamide Intermediates |
||
5-Amino-3-(trifluoromethyl)picolinonitrile | 5-氨基-3-(三氟甲基)氰基吡啶 | 573762-62-6 |
N-Boc-1-aminocyclobutanecarboxylic acid | Boc-1-氨基環(huán)丁烷羧酸 | 120728-10-1 |
1-amino-N-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]Cyclobutanecarboxamide | 1-氨基-N-[6-氰基-5-(三氟甲基)-3-吡啶基]-環(huán)丁烷甲酰胺 | 1950587-17-3 |
磷酸蘆可替尼中間體 Ruxolitinib Phosphate Intermediates |
||
1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | 1-(1-乙氧基乙基)-4-吡唑硼酸頻哪醇酯 | 1029716-44-6 |
3-Cyclopentylacrylonitrile | 3-環(huán)戊基丙烯腈 | 591769-05-0 |
(4-(1-(2-Cyano-1-cyclopentylethyl)-1h-pyrazol-4-yl)-7h-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate | (4-(1-(2-氰基-1-環(huán)戊基乙基)-1h-吡唑-4-基)-7h-吡咯并[2,3-d]嘧啶-7-基)特戊酸甲酯 | 1236033-05-8 |
烏帕替尼中間體 Upadacitinib Intermediates |
||
(3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester | (3R,4S)-3-(2-溴乙酰基)-4-乙基-1-吡咯烷羧酸芐酯 | 1428243-26-8 |
tert-butyl 5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-ylcarbamate | 5-甲苯磺?;?5H-吡咯并[2,3-B]吡嗪-2-胺基甲酸叔丁酯 | 1201187-44-1 |
8-((3R,4S)-4-ethylpyrrolidin-3-yl)-3-tosyl-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine | 8-((3S,4R)-4-乙基吡咯烷-3-基)-3-甲苯磺?;?3H-咪唑并[1,2-a]吡咯并[2,3-e]吡嗪 | 1428243-28-0 |
奧澤沙星中間體 Ozenoxacin Intermediates |
||
ethyl 7-chloro-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate | 奧澤沙星中間體A | 103877-51-6 |
5-broMo-N,3-diMethylpyridin-2-aMine | 奧澤沙星中間體B | 245765-66-6 |
[6-[benzoyl(methyl)amino]-5-methyl-3-pyridyl]boronic acid | 奧澤沙星中間體D | 446299-81-6 |
布林佐胺中間體 Brinzolamide Intermediates |
||
(S)-3,4-dihydro-6-chloro-4-hydroxy-2H-thieno[3,2-e]-1,2-thiazine-1,1-dioxide | (S)-6-氯-3,4-二氫-2H-噻吩并[3,2-e]-1,2-噻嗪-4-醇1,1-二氧化物 | 160982-16-1 |
(S)-3,4-Dihydro-4-hydroxy-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide | (S)-3,4-二氫-4-羥基-2-(3-甲氧基丙基)-2H-噻吩并[3,2-e]-1,2-噻嗪-6-磺胺-1,1-二氧化物 | 154127-42-1 |
鹽酸阿替卡因中間體 Articaine hydrochloride Intermediates |
||
3-Amino-4-methyl-2-thiophene carboxylic acid methyl ester | 3-氨基-4-甲基噻吩-2-甲酸甲酯 | 85006-31-1 |
鹽酸羅哌卡因中間體 Ropivacaine Intermediates |
||
N-(2,6-Dimethylphenyl)-2-piperidinecarboxamide | N-(2,6-二甲苯基)-2-哌啶甲酰胺 | 15883-20-2 |
(2S)-N-(2,6-Dimethylphenyl)-2-piperidinecarboxamide | (S)-N-(2,6-二甲苯基)-2-哌啶甲酰胺 | 27262-40-4 |
別孕酮中間體
Brexanolone Intermediates
|
||
Allopregnan-3β-ol-20-one acetate | 別孕烯醇酮醋酸酯 | 906-83-2 |
3β-hydroxy-5α-pregnan-20-one | 別孕烯醇酮 | 516-55-2 |
氟雷拉納中間體
Fluralaner Intermediates
|
||
4-acetyl-2-methylbenzoic acid | 2-甲基-4-乙酰基苯甲酸 | 55860-35-0 |
2-AMino-N-(2,2,2-trifluoroethyl)acetaMide hydrochloride | 2-氨基-N-(2,2,2-三氟乙基)乙酰胺鹽酸鹽 | 1171331-39-7 |
3',5'-DICHLORO-2,2,2-TRIFLUOROACETOPHENONE | 3', 5'-二氯-2, 2, 2-三氟苯乙酮 | 130336-16-2 |
阿福拉納中間體
Afoxolaner Intermediates
|
||
4-acetyl-1-naphthoic acid | 4-乙?;良姿?/span> | 131986-05-5 |
2-AMino-N-(2,2,2-trifluoroethyl)acetaMide hydrochloride | 2-氨基-N-(2,2,2-三氟乙基)乙酰胺鹽酸鹽 | 1171331-39-7 |
1-[3-Chloro-5-trifluoromethylphenyl]-2,2,2-trifluoroethanone | 1-[3-氯-5-(三氟甲基)苯基]-2,2,2-三氟乙酮 | 1125812-58-9 |
從現(xiàn)有原料藥基礎(chǔ)上進行制劑項目深度挖掘,形成細分領(lǐng)域?qū)I(yè)化MAH路線,已開展11項MAH項目,其中舒更葡糖鈉項目已獲批,利丁卡因制劑已上報至國家局進入臨床研究階段。
CDMO業(yè)務(wù)可承接高端醫(yī)藥中間體、新型農(nóng)化類中間體、寵物藥等獸藥類中間體、大健康類跨界產(chǎn)品及中間體定制與服務(wù)。
聯(lián)系我們
山東誠匯醫(yī)藥集團有限公司
CHENGHUI PHARMACEUTICAL GROUP LTD
藥廠業(yè)務(wù)
沈經(jīng)理 0531-58897066
廖經(jīng)理 0531-58897055
貿(mào)易公司業(yè)務(wù)
李經(jīng)理 0531-58897086
黃經(jīng)理 0531-58897087
唐經(jīng)理 0531-58897051
獸藥業(yè)務(wù)
任經(jīng)理 0531-58897165
市場部
謝經(jīng)理 0531-58897070
人才招聘
李經(jīng)理 0531-58897028
郵箱
sales@jnchsd.com
market@jnchsd.com
官網(wǎng):www.wfggn.com